Saturday, July 11, 2026

Drug profile · INN

lerodalcibep-liga

lerodalcibep-liga (LEROCHOL) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — lerodalcibep-liga
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

lerodalcibep-liga (LEROCHOL) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN lerodalcibep-liga
Brand LEROCHOL
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is lerodalcibep-liga?

lerodalcibep-liga (LEROCHOL) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for lerodalcibep-liga?

LEROCHOL is a marketed brand name for lerodalcibep-liga. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of lerodalcibep-liga?

lerodalcibep-liga has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.